Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Document Physician Rationale for Pharmacy Recommendation

Fort Dodge, Kansas Survey Completed on 08-07-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to act upon a consultant pharmacist's recommendation during the monthly medication regimen review for a resident with diagnoses of depression, anxiety, and pain. The pharmacist identified elevated creatinine levels and low hemoglobin in the resident's laboratory results and recommended considering discontinuation of Celebrex due to potential renal or gastrointestinal involvement. The physician responded to the recommendation by declining to discontinue the medication but did not provide a rationale for this decision, as required by facility policy. Documentation in the resident's electronic health record and care plan confirmed ongoing administration of Celebrex despite the pharmacist's concerns. Interviews with facility staff revealed a lack of understanding regarding the requirement for physicians to document a rationale when not following pharmacy recommendations. The administrative nurse and pharmacy consultant both indicated that a rationale was only necessary for gradual dose reductions of psychotropic medications, not for other pharmacy recommendations. The facility's drug regimen review policy, however, required an appropriate response from physicians concerning previous drug regimen review recommendations or drug irregularities, which was not met in this case.

An unhandled error has occurred. Reload 🗙